Page last updated: 2024-10-26

ethosuximide and Acute Confusional Senile Dementia

ethosuximide has been researched along with Acute Confusional Senile Dementia in 2 studies

Ethosuximide: An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
ethosuximide : A dicarboximide that is pyrrolidine-2,5-dione in which the hydrogens at position 3 are substituted by one methyl and one ethyl group. An antiepileptic, it is used in the treatment of absence seizures and may be used for myoclonic seizures, but is ineffective against tonic-clonic seizures.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Jin, N1
Ziyatdinova, S1
Gureviciene, I1
Tanila, H1
Tiwari, SK1
Seth, B1
Agarwal, S1
Yadav, A1
Karmakar, M1
Gupta, SK1
Choubey, V1
Sharma, A1
Chaturvedi, RK1

Other Studies

2 other studies available for ethosuximide and Acute Confusional Senile Dementia

ArticleYear
Response of spike-wave discharges in aged APP/PS1 Alzheimer model mice to antiepileptic, metabolic and cholinergic drugs.
    Scientific reports, 2020, 07-16, Volume: 10, Issue:1

    Topics: 3-Hydroxybutyric Acid; Action Potentials; Alzheimer Disease; Animals; Anticonvulsants; Atropine; Dis

2020
Ethosuximide Induces Hippocampal Neurogenesis and Reverses Cognitive Deficits in an Amyloid-β Toxin-induced Alzheimer Rat Model via the Phosphatidylinositol 3-Kinase (PI3K)/Akt/Wnt/β-Catenin Pathway.
    The Journal of biological chemistry, 2015, Nov-20, Volume: 290, Issue:47

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; beta Catenin; Cell Differentiation; Cell Prolifer

2015